Provided by Tiger Trade Technology Pte. Ltd.

Armata Pharmaceuticals, Inc.

5.10
+0.680015.38%
Post-market: 5.100.00000.00%19:30 EDT
Volume:111.49K
Turnover:535.48K
Market Cap:189.63M
PE:-0.97
High:5.10
Open:4.42
Low:4.42
Close:4.42
52wk High:16.34
52wk Low:2.40
Shares:37.18M
Float Shares:11.88M
Volume Ratio:1.06
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2744
EPS(LYR):-4.8000
ROE:-3439.35%
ROA:-25.83%
PB:-0.82
PE(LYR):-1.06

Loading ...

BRIEF-Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update

Reuters
·
May 14

Armata Pharmaceuticals Q1 EPS $(3.16) Misses $(0.38) Estimate, Sales $789.000K Up From $491.000K YoY

Benzinga Earnings
·
May 14

Armata Q1 FY26 net loss widens to $115.35 million

Reuters
·
May 14

Armata Pharmaceuticals Inc - Q1 Net Loss $115.3 Mln or $3.16 Loss per Share VS $6.5 Mln or $0.18 Loss Year Ago

THOMSON REUTERS
·
May 14

Armata Pharmaceuticals Inc - Enters Secured Credit Agreement With Innoviva for $25 Mln Maturing in 2029

THOMSON REUTERS
·
May 14

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-Sa02

THOMSON REUTERS
·
May 07

Armata Pharmaceuticals Inc - to Initiate Phase 3 Study of AP-Sa02 in H2 2026

THOMSON REUTERS
·
May 07

Armata reports cryo-EM study maps structure of Pseudomonas phage P7-1

Reuters
·
May 04

Armata Pharma director Daniel Gilmer files initial beneficial ownership statement

Reuters
·
Apr 29

Armata Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 28

Armata Pharmaceuticals appoints Pfizer executive Daniel Gilmer to board

Reuters
·
Apr 27

Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.d. to Its Board of Directors

THOMSON REUTERS
·
Apr 27

Press Release: Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors

Dow Jones
·
Apr 27

Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch

TIPRANKS
·
Apr 08

Armata Pharmaceuticals FY2025 net loss more than doubled to $174 million; revenue slips 5.22% to $4.9 million

Reuters
·
Mar 26

Armata Pharmaceuticals Inc - Q4 2025 Net Loss $-3.42 per Share

THOMSON REUTERS
·
Mar 26

Press Release: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results

Dow Jones
·
Mar 26

Armata Pharmaceuticals delays Q4 and full-year 2025 results announcement

Reuters
·
Mar 19

Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update

THOMSON REUTERS
·
Mar 19

Armata price target raised to $15 from $9 at H.C. Wainwright

TIPRANKS
·
Feb 23